He L - Search Results

1

Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.

He L, Ingram A, Rybak AP, Tang D. He L, et al. J Clin Invest. 2010 Jun;120(6):2094-108. doi: 10.1172/JCI40778. Epub 2010 May 10. J Clin Invest. 2010. PMID: 20458142 Free PMC article.

2

Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression.

Fan C, He L, Kapoor A, Gillis A, Rybak AP, Cutz JC, Tang D. Fan C, et al. Among authors: he l. Biochim Biophys Acta. 2008 Nov;1782(11):642-8. doi: 10.1016/j.bbadis.2008.08.009. Epub 2008 Sep 6. Biochim Biophys Acta. 2008. PMID: 18817867

3

Co-existence of high levels of the PTEN protein with enhanced Akt activation in renal cell carcinoma.

He L, Fan C, Gillis A, Feng X, Sanatani M, Hotte S, Kapoor A, Tang D. He L, et al. Biochim Biophys Acta. 2007 Oct;1772(10):1134-42. doi: 10.1016/j.bbadis.2007.07.001. Epub 2007 Jul 12. Biochim Biophys Acta. 2007. PMID: 17681738

4

ATM activation is accompanied with earlier stages of prostate tumorigenesis.

Fan C, Quan R, Feng X, Gillis A, He L, Matsumoto ED, Salama S, Cutz JC, Kapoor A, Tang D. Fan C, et al. Among authors: he l. Biochim Biophys Acta. 2006 Oct;1763(10):1090-7. doi: 10.1016/j.bbamcr.2006.08.026. Epub 2006 Aug 24. Biochim Biophys Acta. 2006. PMID: 16997395

5

Specific reduction of fas-associated protein with death domain (FADD) in clear cell renal cell carcinoma.

Xu H, He L, Feng X, Kapoor A, Tang D. Xu H, et al. Among authors: he l. Cancer Invest. 2009 Oct;27(8):836-43. doi: 10.1080/07357900902849681. Cancer Invest. 2009. PMID: 19557578

6

PTEN inhibits BMI1 function independently of its phosphatase activity.

Fan C, He L, Kapoor A, Rybak AP, De Melo J, Cutz JC, Tang D. Fan C, et al. Among authors: he l. Mol Cancer. 2009 Nov 10;8:98. doi: 10.1186/1476-4598-8-98. Mol Cancer. 2009. PMID: 19903340 Free PMC article.

7

FAM84B promotes prostate tumorigenesis through a network alteration.

Jiang Y, Lin X, Kapoor A, He L, Wei F, Gu Y, Mei W, Zhao K, Yang H, Tang D. Jiang Y, et al. Among authors: he l. Ther Adv Med Oncol. 2019 May 13;11:1758835919846372. doi: 10.1177/1758835919846372. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31205500 Free PMC article.

8

Common reduction of the Raf kinase inhibitory protein in clear cell renal cell carcinoma.

Hill B, De Melo J, Yan J, Kapoor A, He L, Cutz JC, Feng X, Bakhtyar N, Tang D. Hill B, et al. Among authors: he l. Oncotarget. 2014 Sep 15;5(17):7406-19. doi: 10.18632/oncotarget.1558. Oncotarget. 2014. PMID: 25277181 Free PMC article.

9

SIPL1-facilitated PTEN ubiquitination contributes to its association with PTEN.

De Melo J, Lin X, He L, Wei F, Major P, Tang D. De Melo J, et al. Among authors: he l. Cell Signal. 2014 Dec;26(12):2749-56. doi: 10.1016/j.cellsig.2014.08.013. Epub 2014 Aug 22. Cell Signal. 2014. PMID: 25152374

10

SIPL1 enhances the proliferation, attachment, and migration of CHO cells by inhibiting PTEN function.

De Melo J, Wu V, He L, Yan J, Tang D. De Melo J, et al. Among authors: he l. Int J Mol Med. 2014 Sep;34(3):835-41. doi: 10.3892/ijmm.2014.1840. Epub 2014 Jul 8. Int J Mol Med. 2014. PMID: 25018115

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results